Drug combo at outset of polyarticular JIA benefits patients mostNovember 10, 2021Rare DiseasesMusculoskeletal Disorders
European agency recommends two new adalimumab biosimilarsSeptember 20, 2021Musculoskeletal DisordersDermatologyGastroenterology
Three JAK inhibitors get boxed warnings, modified indicationsSeptember 2, 2021Musculoskeletal DisordersGastroenterology
Study informs about risks of discontinuing meds in JIAAugust 25, 2021Rare DiseasesMusculoskeletal Disorders
AAP updates guidance for return to sports and physical activitiesJune 22, 2021COVID-19 UpdatesMusculoskeletal Disorders
Secukinumab provides clinical benefit in phase 3 juvenile arthritis trialJune 15, 2021Rare DiseasesMusculoskeletal Disorders
Challenges persist in adolescents with rheumatic disease transitioning to adult careApril 30, 2021Musculoskeletal DisordersAdolescent Medicine
TNF inhibitors linked to threefold increased risk of psoriasis in JIA patientsApril 29, 2021DermatologyMusculoskeletal Disorders
Success in achondroplasia spurs testing vosoritide in more growth disordersMarch 21, 2021EndocrinologyMusculoskeletal DisordersRare Diseases
Helping parents and children deal with a child’s limb deformityFebruary 24, 2021Musculoskeletal Disorders
Dan Kastner wins Crafoord Prize in PolyarthritisFebruary 3, 2021ImmunologyRare DiseasesMusculoskeletal Disorders
Greater reductions in knee OA pain seen with supportive rather than flexible shoesJanuary 13, 2021Musculoskeletal Disorders
Data call for biologics trials in undertreated juvenile arthritis subtypeJanuary 7, 2021Musculoskeletal DisordersRare DiseasesAdolescent Medicine
